U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06806072) titled 'BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY' on Jan. 23.
Brief Summary: Endocrine therapy is the mainstay of adjuvant therapy in premenopausal women with hormone receptive-positive (HR+) breast cancer as it has been demonstrated that it reduces long-term recurrences and increases survivial. However, this therapy, which suppresses estrogen production and estrogen-induced effects, is associated with the development of joint pain which can significantly reduce quality of life and lead to treatment discontinuation.
The main question the study aims o answer is:
Can balneotherapy (BT) alleviate muscle-skeletal p...